Pakistan latest patents query
The latest invention patents collect the data information of Pakistan invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
3-fluoro-4-[4-[2-(3,5 dimethylphenyl)pyrrolidin-1-yl methyl]phenoxy]benzamide compound
UndeterminedPK140737A
Owner:ELI LILLY & CO
A process for preparing polyarylcarboxamide useful as lipid lowering agent
UndeterminedPK140603A
Owner:JANSSEN PHARMA NV
A pharmaceutically acceptable salt of a substituted 2-oxoalkyl-1-piperazin 2-one compound
UndeterminedPK201000333A0
Owner:SANOFI AVENTIS SA
Process for making polyethylene terephthalate
UndeterminedPK201000183A0
Owner:SAUDI BASIC INDUSTRIES CORP
A pharmaceutically acceptable salt of a substituted Tetrahydropyrimido[4,5-b][1,4]-5H-diazepin-2-ylamino-methyl piperidin-4-ylbenzamide compound
UndeterminedPK201000421A0
Owner:TAKEDA PHARMA CO LTD
Process for oxidative dehydrogenation using a boria-alumina catalyst.
UndeterminedPK140621A
Owner:SAUDI BASIC INDUSTRIES CORP
Production of carbon dioxide and power from a hydrocarbon feedstock
UndeterminedPK201000227A0
Owner:HYDROGEN ENERGY INT
Small crystal salt production by solar evaporation in salt beds
UndeterminedPK201000419A0
Owner:MUJEEB UR REHMAN ALVI
1h-pyrazolo[4,3-e]isoquinoline derivatives, their preparation and their application in therapeutics
UndeterminedPK201000334A0
Owner:SANOFI AVENTIS SA
Bicyclic compounds as inhibitors of diacylclycertol acyltransferase
UndeterminedPK201000201A0
Owner:SCHERING CORP
Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
UndeterminedPK201000406A0
Owner:JANSSEN PHARMA NV
Antitumour combination comprising ave8062 and sorafenib
UndeterminedPK201000380A0
Owner:SANOFI AVENTIS SA
Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation and therapeutic use thereof
UndeterminedPK201000392A0
Owner:SANOFI AVENTIS SA
Process for the preparation of instant natural food supplement
UndeterminedPK201000251A0
Owner:MR SAEED AKTHER +1
Process for preparation of pharmaceutical composition comprising VX478 and a water soluble vitamin E compound.
UndeterminedPK140581A
Owner:GLAXO GROUP LTD
Pipobroman and chitosan nanoparticles-mediated modulation of mitogenactivated protein kinase cascade in liver and glioblastoma cancer cells: in vitro and in vivo studies
PendingPK202600777A0
Owner:HAFIZA SWAIBA AFZAL PHD SCHOLAR IMBB
A process for modification of recombinant human interferon for therapeutic use
UndeterminedPK140586A
Owner:NAT CENT OF EXCELLENCE IN MOLECULAR BIOLOGY
Inhibitors of human immunodeficiency virus replication
UndeterminedPK201000412A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one
UndeterminedPK201000195A0
Owner:ALMIRALL SA
A process for manufacturing of personal decontamination kit (pdk)
ActivePK201000204A0
Owner:DEFENCE SCI & TECH ORG (DESTO)
Aerosol composition for inhalation containing a tiotropium salt
UndeterminedPK140634A
Owner:BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
Salt of compound comprising 1,2-di(cyclic) substituted benzene, pharmaceutical composition
UndeterminedPK140714A
Owner:EISAI R&D MANAGEMENT CO LTD
Non-invasive energy upconversion methods and systems for in-situ photobiomodulation
UndeterminedPK201000327A0
Owner:IMMUNOLIGHT LLC +1
A magnetocaloric generator with increased calorific power and economic profitability comprising integrated means to force circulation of thermal fluid.
UndeterminedPK140656A
Owner:COOLTECH APPL SAS
A Process for the Production of herbal, hala and perfume free soap
UndeterminedPK140743A
Owner:NIGHAT AFZA +3
Isolated polynucleotides and polypeptides, and methods of using same for Increasing plant yield and / or agricultural characteristics.
UndeterminedPK201000154A0
Owner:EVOGENE INC
Pharmaceutically acceptable salt of a substituted phenyl-alkylpiperazine compound
UndeterminedPK201000310A0
Owner:SANOFI AVENTIS SA
Improved therapeutic sclerosing microfoam comprising phesiologicaly acceptable gas.
UndeterminedPK140613A
Owner:BTG INTERNATIONAL LTD
Sealing element for heat sealing packaging material for producing sealed packages of food products pourable within a tube of packaging material
UndeterminedPK201000250A0
Owner:TETRA LAVAL HOLDINGS & FINANCE SA
Novel storage-stable aqueous concentrate comprising glyphosate and trifloxysulfuron as active ingredients
UndeterminedPK140778A
Owner:SYNGENTA IP
Circular knitting machine having integrated multiple yarn changing apparatus
UndeterminedPK201000284A0
Owner:PAI LUNG MACHINERY MILL CO LTD
An improved codon optimized human in terferon
UndeterminedPK140574A
Owner:NAT CENT OF EXCELLENCE IN MOLECULAR BIOLOGY
Bridged bicyclic heterocycle derivatives and methods of use thereof
UndeterminedPK201000268A0
Owner:SCHERING CORP
Topical cosmetic skin lightening compositions and methods of use thereof
UndeterminedPK140624A
Owner:STIEFEL LABORATORIES INC
Open web stud with low thermal conductivity and screwreceiving recesses
UndeterminedPK201000401A0
Owner:ERNEST R BODNAR
A pharmaceutical composition comprising thiazolidinedione and an insulin secretagogue.
UndeterminedPK140631A
Owner:SMITHKLINE BEECHAM PLC
Method for genetic control of insect infestation in plant and composition thereof
UndeterminedPK140748A
Owner:MONSANTO TECHNOLOGY LLC
A process for the detection of cytochrome P450 2D6 gene variants
UndeterminedPK140679A
Owner:SAGHEER AHMED
Method for controlling the material feed to a roller mill and such mill
UndeterminedPK201000241A0
Owner:F L SMIDTH & CO AS
Process for the preparation of a water soluble mono-lysine salt of ((2R,3R)-3 (4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4 difluorophenyl)-1-(1H-1,1,2,4-triazol-1 yl)butan-2-yloxy)methyl dihydrogen phosphate
UndeterminedPK140696A
Owner:EISAI R&D MANAGEMENT CO LTD
A pharmaceutically acceptable salt of a heteroarylcarbamoylbenzene compound and a pharmaceutical composition comprising the same
UndeterminedPK140601A
Owner:BANYU PHARMA CO LTD
A triplex fluorogenic probe based real-time quantitative PCR assay for the detection of SARS-COV-2 specific E protein and RdRp genes in human samples
PendingPK144887A
Owner:NAT INST FOR BIOTECHNOLOGY & GENETIC ENG (NIBGE)
A pharmaceutically acceptable salt of a substituted 2,6-quinolinyl and 2,6 naphthyl compound
UndeterminedPK140688A
Owner:UCB PHARMA SA
4-[5-(2-amino-ethanesulfonyl)-isoquinolin-7-yl]-phenol compound
UndeterminedPK140571A
Owner:ELI LILLY & CO
Paediatric solutions for beta blockers
UndeterminedPK201000315A0
Owner:PIERRE FABRE DERMO COSMETIQUE SA
Catalyst composition and process for oligomerization of ethylene
UndeterminedPK201000295A0
Owner:LINDE AG +1
Dialysis machine, a manifold for the dialysis machine and process.
UndeterminedPK201000152A0
Owner:VIFOR (INT) AG
Ethyl 3-[(2-{[4-((hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulphonate
UndeterminedPK140585A
Owner:BOEHRINGER INGELHEIM INT GMBH
1-alkylcinnolin-4(1h)-one derivatives, their preparation and their therapeutic application
UndeterminedPK201000281A0
Owner:SANOFI AVENTIS SA
Salinity gradient power reverse electrodialysis plant and use thereof
UndeterminedPK140746A
Owner:VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK NV (VITO)
Substituted isoxazol-3 ylcarbamoylmethyl-1-azonia bicyclo[2.2.2]octane compound
UndeterminedPK140685A
Owner:NOVARTIS AG
7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
UndeterminedPK201000395A0
Owner:SANOFI AVENTIS SA
Top roller carrying and weighting arm for a drafting arrangement
UndeterminedPK201000214A0
Owner:SAURER COMPONENTS GMBH
Compounds and methods for antiviral treatment government support
UndeterminedPK201000272A0
Owner:SCHERING CORP +1
A pharmaceutically acceptable salt of a tetrahydrocyclopenta[b]indole compound
UndeterminedPK140584A
Owner:ELI LILLY & CO
A process for the detection of cytochrome P450 2C9 gene variants
UndeterminedPK140661A
Owner:SAGHEER AHMED
A transaction system comprising electronic transaction terminal and a computer server for receiving and transmitting transaction data
UndeterminedPK140598A
Owner:ONEEMPOWER PTE LTD
Therapeutic applications of quinazolinedione derivatives
UndeterminedPK201000240A0
Owner:SANOFI AVENTIS SA
Inhibition of Oral Squamous Cell Carcinoma Growth By Synergistic Interaction of Motesanib And ML364
PendingPK202600768A0
Owner:ZEHRA HASHIM +3
Process and system for producing potable water
UndeterminedPK201000280A0
Owner:DEWATERING FILTRATION TECH SERVICES
New process for the synthesis of ivabradine and addition S.A.,lts thereof with a pharmaceutically acceptable acid
UndeterminedPK201000238A0
Owner:LES LAB SERVIER SA
A vaccine composition comprising a sterol and / or alpha-tocopherol, a metabolisable oil and an emulsifying agent,method of its preparation and use for immunizing against influenza disease
UndeterminedPK140615A
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
A salt, solvate and / or solvate of the salt of a substituted dihydroquinazoline compound
UndeterminedPK140717A
Owner:AICURIS GMBH & CO KG
Substituted n-(heteroary)-1h-indole-2-carboxamide compound.
UndeterminedPK140552A
Owner:SANOFI AVENTIS SA
Process for separating dissolved somponents from a solution.
UndeterminedPK140650A
Owner:SURREY AQUA TECH
Pyrazolo[1,5-a]pyimidine derivatives as novel mtor inhibitors
UndeterminedPK201000302A0
Owner:SCHERING CORP
Method for the production of a granulate from dates
UndeterminedPK140782A
Owner:GRANMALT BREWING SOLUTIONS
A salt of [(1r)-3-(diisopropylamino) 1-phenylpropyl]-4-hydroxyphenyl derivatives useful as dual b2 adrenergic receptor agonists and muscarinic receptor antagonists
UndeterminedPK201000318A0
Owner:PFIZER LTD
Enzymatic textile bleach-whitening methods
UndeterminedPK201000160A0
Owner:HUNTSMAN ADVANCED MATERIALS AMERICAS LLC
Circular knitting machine jacquard needle equipped with a return structure
UndeterminedPK201000259A0
Owner:PAI LUNG MACHINERY MILL CO LTD
A process for preparation of new spasmolytic composition from psidium guajava leaves
UndeterminedPK140597A
Owner:DR SABIRA BEGUM +4
Hydraulic compressed natural gas filling equipment and gas filling control method
UndeterminedPK201000210A0
Owner:ENRIC (LANGFANG) ENERGY EQUIP INTEGRATION CO LTD
Antibody glycosylation in the variable region of heavy chain (VH) in antibody molecules specifically recognizing Aß4.
UndeterminedPK140568A
Owner:F HOFFMANN LA ROCHE & CO AG
Herbicidal synergistic composition comprising trifloxysulfuron
UndeterminedPK140590A
Owner:SYNGENTA PARTICIPATIONS AG
An immunogenic composition comprising a rotavirus antigen.
UndeterminedPK140639A
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
Combination of tetrahydroimidazopyridine substituted tropane compound and additional therapeutical agent particularly
UndeterminedPK140738A
Owner:PFIZER INC
A pharmaceutical salt composition containing piperacillin and tazobactam.
UndeterminedPK140546A
Owner:WYETH HOLDINGS CORP
8-(3-amino-piperidin-1-yl)-xanthines compound and pharmaceutical compositions comprising thereof
UndeterminedPK201000301A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Herbicidal composition comprising herbicidally active hppd (hydroxy phenyl pyruvate dioxygenase inhibitor and surfactant comprising at least 10 alkylene oxide unit
UndeterminedPK140663A
Owner:BAYER CROPSCIENCE AG
Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
UndeterminedPK201000180A0
Owner:BAYER SCHERING PHARMA AG
Pharmaceutically acceptable salt of a substituted 2-carbonylamino-6 piperidinaminopyridine
UndeterminedPK140740A
Owner:ELI LILLY & CO
N-[4-chloro-2-hydroxy-3-(piperazine-1-sulfonyl)phenyl]-n'-(2-chloro-3-fluorophenyl)urea, p-toluenesulfonic acid salt.
UndeterminedPK140572A
Owner:SMITHKLINE BEECHAM CORP
Cyclic inhibitors of 11beta hydroxysteroid dehydrogenase 1
UndeterminedPK201000357A0
Owner:BOEHRINGER INGELHEIM INT GMBH +1
A multi-layer controlled release tablet comprising a matrix comprising hydrophilic polymeric substance and lipophilic substance.
UndeterminedPK140611A
Owner:JAGOTEC AG
Highly stable pt-sn-based, sapo 34 supported, al binded catalyst, and integrated fluidized bed reactor design for alkane dehydrogenation
UndeterminedPK200901127A0
Owner:ENGR DR ZEESHAN NAWAZ +2
Derivatives of 6-cycloamino-2 thienyl-3-(pyridin-4 yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3 (pyridin-4-yl)imidazo[1,2-b] pyridazine, preparation thereof and therapeutic use thereof
UndeterminedPK200901155A0
Owner:SANOFI AVENTIS SA
Process, plant, and butanol from lignocellulosic feedstock
UndeterminedPK200901136A0
Owner:BP BIOFUELS UK
Deterministic Field-Level Video Acquisition and DMA-Triggered File System Streaming System for Embedded Microcontroller Platforms
PendingPK202600816A0
Owner:SOAN ENTERPRISES
(4-tert-butylpiperazin-2 yl)(piperazin-1-yl)methanone-n carboxamide derivatives
UndeterminedPK200901115A0
Owner:ASTRAZENECA AB